Introduction
Soluble Fas (sFas) levels are associated with anemia and erythropoietin (Epo) hyporesponsiveness in chronic kidney disease. Anemia is also a common feature in patients with acute renal failure (ARF) and in critically ill patients. Therefore, it is possible that sFas levels are also associated with anemia and increased need for serum Epo levels in ARF and critical illness in order to maintain hemoglobin (Hgb) levels.
Objective
To investigate the relationship between serum levels of sFas, Epo, inflammatory cytokines and Hgb levels in patients with ARF and critically ill patients.
Methods
We studied 72 critically ill patients with ARF on continuous hemodiafiltration (CVVHDF group; n = 53) or without ARF (non-ARF group; n = 19), 29 chronic hemodialysis patients (ESRD group) and 29 healthy volunteers (Healthy group). The CVVHDF dose was 30 ml/kg per hour or higher. We investigated among the four groups the relationships between Hgb and serum levels of sFas, Epo, TNFα, IL-6, IL-10 and iron status.
Results
The CVVHDF and non-ARF groups had higher serum levels of Epo, IL-6, IL-10 and ferritin than the other groups. Hgb levels were lower in the CVVHDF group than in the other groups. Serum sFas levels were higher in uremic patients (CVVHDF and ESRD groups; P < 0.001). When all critically ill patients were pooled together, Hgb levels correlated negatively with serum levels of IL-6 (r = -0.55, P = 0.001), sFas (r = -0.40, P = 0.001), TNFα (r = -0.37, P < 0.001), iron (r = -0.28, P = 0.02), ferritin (r = -0.35, P = 0.004) and transferrin saturation (r = -0.30, P = 0.01). In multivariate analysis, after adjusting for markers of iron store and inflammation, levels of IL-6 (P < 0.001), sFas (P < 0.001) and TNFα (P = 0.01) correlated negatively with Hgb in critically ill patients.
Conclusion
Our findings demonstrate that sFas is associated with anemia in ARF and critically ill patients. Serum sFas and Epo levels were higher and Hgb levels were lower in critically ill patients with ARF, suggesting that sFas may be associated with Epo hyporesponsiveness in ARF and critical illness.
Author information
Authors and Affiliations
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Góes, M., Dalboni, M., Quinto, B. et al. Serum soluble-Fas, inflammation and anemia in acute renal failure and critical illness. Crit Care 15 (Suppl 2), P34 (2011). https://doi.org/10.1186/cc10182
Published:
DOI: https://doi.org/10.1186/cc10182